Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001198350 | SCV001369254 | uncertain significance | Atelosteogenesis type III | 2019-10-02 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Labcorp Genetics |
RCV003770217 | SCV004665099 | uncertain significance | not provided | 2023-05-15 | criteria provided, single submitter | clinical testing | This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FLNB protein function. ClinVar contains an entry for this variant (Variation ID: 931610). This variant has not been reported in the literature in individuals affected with FLNB-related conditions. This sequence change replaces threonine, which is neutral and polar, with lysine, which is basic and polar, at codon 806 of the FLNB protein (p.Thr806Lys). |